1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          APAC Compounding Pharmacies Market – By Product

1.3.2          APAC Compounding Pharmacies Market – By Therapeutic Area

1.3.3          APAC Compounding Pharmacies Market– By Country

2.           APAC Compounding Pharmacies Market– Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           APAC Compounding Pharmacies Market– Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Asia Pacific PEST Analysis

4.3          Expert Opinion

5.           APAC Compounding Pharmacies Market – Key Market Dynamics

5.1          Market Drivers

5.1.1          Drug Shortage Crisis

5.1.2          Benefits of Compounded Medications

5.1.3          Growing Adoption of Customized Medicine (Personalized Medicine)

5.2          Market Restraints

5.2.1          Product Recalls and Stringent Regulatory Requirements

5.3          Market Opportunities

5.3.1          Increasing Demand for Compounding Pharmacy During COVID-19

5.4          Future Trends

5.4.1          Rise in Outsourcing Facilities for Manufacturing and Sales of Products

5.5          Impact Analysis

6.           Compounding Pharmacies Market– APAC Analysis

6.1          APAC Compounding Pharmacies Market Revenue Forecast and Analysis

7.           APAC Compounding Pharmacies Market Analysis – By Product

7.1          Overview

7.2          APAC Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

7.3          Oral Medications

7.3.1          Overview

7.3.2          Oral Medications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Topical Medications

7.4.1          Overview

7.4.2          Topical Medications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Suppositories

7.5.1          Overview

7.5.2          Suppositories: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Others

7.6.1          Overview

7.6.2          Others: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.           APAC Compounding Pharmacies Market – By Therapeutic Area

8.1          Overview

8.2          APAC Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

8.3          Pain Medications

8.3.1          Overview

8.3.2          Pain Medications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Hormone Replacement Therapies

8.4.1          Overview

8.4.2          Hormone Replacement Therapies: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Dermatological Applications

8.5.1          Overview

8.5.2          Dermatological Applications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Others

8.6.1          Overview

8.6.2          Others: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.           APAC Compounding Pharmacies Market Revenue and Forecasts to 2028 – Country Analysis

9.1          Asia Pacific: Compounding Pharmacies Market

9.1.1          Overview

9.1.2          Asia Pacific: Compounding Pharmacies Market - Revenue and Forecast to 2028 (USD Million)

9.1.3          Asia Pacific: Compounding Pharmacies Market, by Country, 2020 & 2028 (%)

9.1.4          China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.4.1             China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.4.2             China: Compounding Pharmacies Market, by Product, Revenue and Forecast to 2028 (USD Million)

9.1.4.3             China: Compounding Pharmacies Market, by Therapeutic Area, Revenue and Forecast to 2028 (USD Million)

9.1.5          Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.1             Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2             Japan: Compounding Pharmacies Market, by Product, Revenue and Forecast to 2028 (USD Million)

9.1.5.3             Japan: Compounding Pharmacies Market, by Therapeutic Area, Revenue and Forecast to 2028 (USD Million)

9.1.6          India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.1             India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.2             India: Compounding Pharmacies Market, by Product, Revenue and Forecast to 2028 (USD Million)

9.1.6.3             India: Compounding Pharmacies Market, by Therapeutic Area, Revenue and Forecast to 2028 (USD Million)

9.1.7          South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.1             South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.2             South Korea: Compounding Pharmacies Market, by Product, 2018–2028 (USD Million)

9.1.7.3             South Korea: Compounding Pharmacies Market, by Therapeutic Area, Revenue and Forecast to 2028 (USD Million)

9.1.8          Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.1             Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.2             Australia: Compounding Pharmacies Market, by Product, Revenue and Forecast to 2028 (USD Million)

9.1.8.3             Australia: Compounding Pharmacies Market, by Therapeutic Area, 2018–2028 (USD Million)

9.1.9          Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.9.1             Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

9.1.9.2             Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

9.1.9.3             Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on APAC Compounding Pharmacies Market

10.1        Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.        Compounding Pharmacies Market– Industry Landscape

11.1        Overview

11.2        Organic Developments

11.2.1        Overview

11.3        Inorganic Developments

11.3.1        Overview

12.        Company Profiles

12.1        Fagron, Inc.

12.1.1        Key Facts

12.1.2        Business Description

12.1.3        Products and Services

12.1.4        Financial Overview

12.1.5        SWOT Analysis

12.1.6        Key Developments

12.2        B.Braun Melsungen AG

12.2.1        Key Facts

12.2.2        Business Description

12.2.3        Products and Services

12.2.4        Financial Overview

12.2.5        SWOT Analysis

12.2.6        Key Developments

12.3        Fresenius Kabi AG

12.3.1        Key Facts

12.3.2        Business Description

12.3.3        Products and Services

12.3.4        Financial Overview

12.3.5        SWOT Analysis

12.3.6        Key Developments

12.4        Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd.

12.4.1        Key Facts

12.4.2        Business Description

12.4.3        Products and Services

12.4.4        Financial Overview

12.4.5        SWOT Analysis

12.4.6        Key Developments

12.5        Elixir Compounding Pharmacy

12.5.1        Key Facts

12.5.2        Business Description

12.5.3        Products and Services

12.5.4        Financial Overview

12.5.5        SWOT Analysis

12.5.6        Key Developments

13.        Appendix

13.1        About the Insight Partners

13.2        Glossary of Terms

LIST OF TABLES

Table 1.              APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ million)

Table 2.              China Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.              China Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 4.              Japan Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 5.              Japan Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 6.              India Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 7.              India Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 8.              South Korea Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 9.              South Korea Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 10.            Australia Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 11.            Australia Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 12.            Rest of Asia-Pacific: Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 13.            Rest of Asia-Pacific: Compounding Pharmacies Market, by Therapeutic Area – Revenue and Forecast to 2028 (USD Million)

Table 14.            Organic Developments Done By Companies

Table 15.            Inorganic Developments Done By Companies

Table 16.            Glossary of Terms, Compounding Pharmacies Market

LIST OF FIGURES

Figure 1.            APAC Compounding Pharmacies Market Segmentation

Figure 2.            APAC Compounding Pharmacies Segmentation, By Country

Figure 3.            APAC Compounding Pharmacies Market Overview

Figure 4.            Oral Medications Held Largest Share of Product Segment in APAC Compounding Pharmacies Market

Figure 5.            China to Show Remarkable Growth During Forecast Period

Figure 6.            Asia Pacific: PEST Analysis

Figure 7.            APAC Compounding Pharmacies Market Impact Analysis of Drivers and Restraints

Figure 8.            APAC Compounding Pharmacies Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.            APAC Compounding Pharmacies Market Revenue Share, by Product (2020 and 2028)

Figure 10.          Oral Medications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Topical Medications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Suppositories: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Others: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          APAC Compounding Pharmacies Market, by Therapeutic Area, 2020 and 2028 (%)

Figure 15.          Pain Medications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.          Hormone Replacement Therapies: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Dermatological Applications: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Others: APAC Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Asia Pacific: Compounding Pharmacies Market, by Key Country – Revenue (2020) (USD Million)

Figure 20.          China: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 21.          Japan: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 22.          India: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 23.          South Korea: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.          Australia: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.          Rest of Asia-Pacific: Compounding Pharmacies Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.          Impact of COVID-19 Pandemic in Asia Pacific Country Markets